🎙️ REPLAY: “Your FDA Timeline Doubled. Your Dev Team Still Burning $50K/Month. Now What?”

This is the cashflow crisis most MedTech founders don’t talk about—until they’re already in it.

I went live with Barend Smet, President of Thaumatec, to break down how smart CEOs are navigating regulatory delays without torching their runway or killing momentum.

💡 Key takeaways:

• How to flex your dev capacity without sacrificing IP or product velocity
• When to pause, scale, or pivot without spooking investors
• The burn multiple red flags that signal you're heading into trouble
• How to turn downtime into strategic upside

LinkedIn | WEBSITE